Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 21, 2009; 15(27): 3426-3430
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3426
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3426
HLA typing | CDC cross-match pre-OLT | DSA | |||
Donor | Recipient | Pre-OLT | At the time of AR | ||
Case 1 | A2 A3 | A3 A36 | Positive on T and B cells | Anti-A2 | Anti-A2 |
B35 B44 | B7 B35 | Anti-DR7 | Anti-DR7 | ||
DR7 DR11 | DR15 - | Anti-B17 | |||
Case 2 | A2 A24 | A3 A29 | Positive on T and B cells | Anti-A2 | Anti-A2 |
B27 B38 | B7 B60 | Anti-A24 | Anti-A24 | ||
DR4 DR11 | DR7 DR13 | Anti-B27 | Anti-B27 | ||
Anti-DR4 |
- Citation: Kamar N, Lavayssière L, Muscari F, Selves J, Guilbeau-Frugier C, Cardeau I, Esposito L, Cointault O, Nogier MB, Peron JM, Otal P, Fort M, Rostaing L. Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation. World J Gastroenterol 2009; 15(27): 3426-3430
- URL: https://www.wjgnet.com/1007-9327/full/v15/i27/3426.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3426